Cognitive and motor function in long-duration PARKIN-associated parkinson disease

JAMA Neurology

Volumn 71, Issue 1, 2014, Pages 62-67

  Alcalay, Roy N ^a   Caccappolo, Elise ^a   Mejia Santana, Helen ^a   Tang, Ming Xin ^a   Rosado, Llency ^a   Reilly, Martha Orbe ^a   Ruiz, Diana ^a   Louis, Elan D ^a,b,c   Comella, Cynthia L ^d   Nance, Martha A ^e   Bressman, Susan B ^f,g   Scott, William K ^h   Tanner, Caroline M ⁱ   Mickel, Susan F ^j   Waters, Cheryl H ^a   Fahn, Stanley ^a   Cote, Lucien J ^a,b   Frucht, Steven J ^a   Ford, Blair ^a   Rezak, Michael ^k   Novak, Kevin E ^l,m   Friedman, Joseph H ^n,o   Pfeiffer, Ronald F ^p   Marsh, Laura ^q   Hiner, Bradley ^r   Payami, Haydeh ^s   Molho, Eric ^t   Factor, Stewart A ^u   Nutt, John G ^v   Serrano, Carmen ^w   Arroyo, Maritza ^w   Ottman, Ruth ^a,b,c,x   Pauciulo, Michael W ^y   Nichols, William C ^y   Clark, Lorraine N ^a   Marder, Karen S ^a,b,z   more..

^a Department of Neurology College of Physicians and Surgeons Columbia University ^*  (United States)

^b Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^c Gertrude H Sergievsky Center College of Physicians and Surgeons Columbia University ^*  (United States)

^d RUSH UNIVERSITY MEDICAL CENTER   (United States)

^e PARK NICOLLET CLINIC   (United States)

^f BETH ISRAEL MEDICAL CENTER   (United States)

^g ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^h UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

ⁱ STANFORD UNIVERSITY   (United States)

^j MARSHFIELD CLINIC   (United States)

^k CENTRAL DUPAGE HOSPITAL   (United States)

^l NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^m UNIVERSITY OF CHICAGO   (United States)

ⁿ BUTLER HOSPITAL   (United States)

^o BROWN UNIVERSITY   (United States)

^p UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^q JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^r MEDICAL COLLEGE OF WISCONSIN   (United States)

^s WADSWORTH CENTER   (United States)

^t ALBANY MEDICAL CENTER   (United States)

^u EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^v OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^w UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

^x NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^y UNIVERSITY OF CINCINNATI   (United States)

^z NewYork Presbyterian Hospital   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PARKIN; UBIQUITIN PROTEIN LIGASE;

AGED; CLINICAL TRIAL; COGNITIVE DEFECT; CROSS-SECTIONAL STUDY; DISEASE COURSE; FEMALE; GENETICS; HETEROZYGOTE; HUMAN; MALE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; ONSET AGE; PARKINSON DISEASE; PATHOPHYSIOLOGY; PSYCHOMOTOR DISORDER;

AGE OF ONSET; AGED; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; MOTOR SKILLS DISORDERS; PARKINSON DISEASE; UBIQUITIN-PROTEIN LIGASES;

EID: 84892375063     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2013.4498     Document Type: Article

References (28)

1. Lücking C.B., Dürr A, Bonifati V., et al.; French Parkinson's Disease Genetics Study Group; European Consortium on Genetic Susceptibility in Parkinson's Disease. Association between early-onset Parkinson's disease and mutations in the parkin gene. N Engl J Med. 2000; 342(21):1560-1567.
2. Caccappolo E, Alcalay RN, Mejia-Santana H, et al Neuropsychological profile of parkin mutation carriers with and without parkinson disease: the CORE-PD study. J Int Neuropsychol Soc. 2011; 17(1):91-100.
3. Lohmann E, Thobois S, Lesage S., et al.; French Parkinson's Disease Genetics Study Group. A multidisciplinary study of patients with early-onset PD with and without parkin mutations. Neurology. 2009; 72(2):110-116.
4. Klein C, Lohmann K. Parkinson disease(s): is "Parkin disease" a distinct clinical entity? Neurology. 2009; 72(2):106-107.
5. Alcalay RN, Caccappolo E, Mejia-Santana H, et al Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study. Arch Neurol. 2010; 67(9):1116-1122.
6. Marder KS, Tang MX, Mejia-Santana H, et al Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study. Arch Neurol. 2010; 67(6):731-738.
7. Pankratz N, Kissell DK, Pauciulo M.W., et al.; Parkinson Study Group-PROGENI Investigators. Parkin dosage mutations have greater pathogenicity in familial PD than simple sequence mutations. Neurology. 2009; 73(4):279-286.
8. Kay DM, Moran D, Moses L., et al Heterozygous parkin point mutations are as common in control subjects as in Parkinson's patients. Ann Neurol. 2007; 61(1):47-54.
9. Clark LN, Wang Y, Karlins E., et al Frequency of LRRK2 mutations in early- and late-onset Parkinson disease. Neurology. 2006; 67(10):1786-1791.
10. Clark LN, Ross BM, Wang Y, et al Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease. Neurology. 2007; 69(12):1270-1277.
11. Alcalay RN, Caccappolo E, Mejia-Santana H, et al Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study. Neurology. 2012; 78(18):1434-1440.
12. Fahn S. ERMotUDC: the Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, eds. Recent Developments in Parkinson's Disease. Florham Park, NJ: Macmillan Healthcare Information; 1987.
13. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993; 43(11):2412-2414.
14. Muslimović D, Post B, Speelman JD, De Haan RJ, Schmand B. Cognitive decline in Parkinson's disease: a prospective longitudinal study. J Int Neuropsychol Soc. 2009; 15(3):426-437.
15. Muslimovic D, Post B, Speelman J.D., Schmand B. Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology. 2005; 65(8):1239-1245.
16. Petersen RC, Doody R, Kurz A., et al Current concepts in mild cognitive impairment. Arch Neurol. 2001; 58(12):1985-1992.
17. Lohmann E, Periquet M, Bonifati V., et al.; French Parkinson's Disease Genetics Study Group; European Consortium on Genetic Susceptibility in Parkinson's Disease. How much phenotypic variation can be attributed to parkin genotype? Ann Neurol. 2003; 54(2):176-185.
18. Khan NL, Graham E, Critchley P., et al Parkin disease: a phenotypic study of a large case series. Brain. 2003; 126(pt 6):1279-1292.
19. Benbunan BR, Korczyn AD, Giladi N. Parkin mutation associated parkinsonism and cognitive decline, comparison to early onset Parkinson's disease. J Neural Transm. 2004; 111(1):47-57.
20. Hedrich K, Marder K, Harris J., et al Evaluation of 50 probands with early-onset Parkinson's disease for Parkin mutations. Neurology. 2002; 58(8):1239-1246.
21. Macedo MG, Verbaan D, Fang Y., et al Genotypic and phenotypic characteristics of Dutch patients with early onset Parkinson's disease. Mov Disord. 2009; 24(2):196-203.
22. Poulopoulos M, Cortes E, Vonsattel J.P., et al Clinical and pathological characteristics of LRRK2 G2019S patients with PD. J Mol Neurosci. 2012; 47(1):139-143.
23. Doherty KM, Silveira-Moriyama L, Parkkinen L., et al Parkin disease: a clinicopathologic entity? JAMA Neurol. 2013; 70(5):571-579.
24. Irwin DJ, White MT, Toledo J.B., et al Neuropathologic substrates of Parkinson disease dementia. Ann Neurol. 2012; 72(4):587-598.
25. Alcalay RN, Siderowf A, Ottman R., et al Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD study. Neurology. 2011; 76(4):319-326.
26. Sakanaka K, Waters CH, Levy O.A., et al Knowledge of and interest in genetic results among Parkinson disease patients and caregivers [published online June 9, 2013]. J Genet Couns. doi:10.1007/s10897-013-9618-y.
27. Falcone DC, Wood EM, Xie S.X., Siderowf A., Van Deerlin VM. Genetic testing and Parkinson disease: assessment of patient knowledge, attitudes, and interest. J Genet Couns. 2011; 20(4):384-395.
28. Tan EK, Jankovic J. Genetic testing in Parkinson disease: promises and pitfalls. Arch Neurol. 2006; 63(9):1232-1237.